[1]
Gul, M.H., Wardak, A.B. and Waheed, A. 2024. Navigating a paradigm shift; food and drug administration approved Tarlatamab-dlle redefining the landscape of small cell lung cancer therapy. International Journal of Scientific Reports. 10, 8 (Jul. 2024), 303–304. DOI:https://doi.org/10.18203/issn.2454-2156.IntJSciRep20241995.